| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45629-089-01 | 45629-089 | HUMAN PRESCRIPTION DRUG | FOTIVDA | Tivozanib | CAPSULE | ORAL | 20210310 | N/A | NDA | NDA212904 | AVEO Pharmaceuticals, Inc. | TIVOZANIB HYDROCHLORIDE | .89 mg/1 | 24 BOTTLE, PLASTIC in 1 CARTON (45629-089-01) / 21 CAPSULE in 1 BOTTLE, PLASTIC |
| 45629-134-01 | 45629-134 | HUMAN PRESCRIPTION DRUG | FOTIVDA | Tivozanib | CAPSULE | ORAL | 20210310 | N/A | NDA | NDA212904 | AVEO Pharmaceuticals, Inc. | TIVOZANIB HYDROCHLORIDE | 1.34 mg/1 | 24 BOTTLE, PLASTIC in 1 CARTON (45629-134-01) / 21 CAPSULE in 1 BOTTLE, PLASTIC |